In the second part of our 'Building a Biotech' series, our CEO Vivienne Williams reflects on her time at the European Commission workshop on Technology Transfer in Nanotechnology in Lecce, Italy on the 18th and 19th October, and gives more information on why technology transfer and IP are important for biotechs. 

This week, I attended the European Commission's workshop on tech transfer in...

Our CEO Vivienne Williams talks about LES 2018 and why IP is important for Cellix, for biotech start-ups in general, and for industry, innovation, universities and consumers.

Please reload

Featured Posts

5 Fantastic Findings On Thrombosis Using Cellix Tech In 2019

October 18, 2019

1/6
Please reload

Recent Posts